| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Animal Models of Osteoarthritis: Challenges of Model Selection and Analysis
|
Teeple, Erin
|
|
2013
|
15 |
2 |
p. 438-446
|
artikel
|
| 2 |
A Sensitivity Analysis of the Modified Chi-square Ratio Statistic for Equivalence Testing of Aerodynamic Particle Size Distribution
|
Weber, Benjamin
|
|
2013
|
15 |
2 |
p. 465-476
|
artikel
|
| 3 |
A Workflow Example of PBPK Modeling to Support Pediatric Research and Development: Case Study with Lorazepam
|
Maharaj, A. R.
|
|
2013
|
15 |
2 |
p. 455-464
|
artikel
|
| 4 |
Chemical Imaging of Drug Delivery Systems with Structured Surfaces–a Combined Analytical Approach of Confocal Raman Microscopy and Optical Profilometry
|
Kann, Birthe
|
|
2013
|
15 |
2 |
p. 505-510
|
artikel
|
| 5 |
Coexistence of Passive and Proton Antiporter-Mediated Processes in Nicotine Transport at the Mouse Blood–Brain Barrier
|
Cisternino, Salvatore
|
|
2012
|
15 |
2 |
p. 299-307
|
artikel
|
| 6 |
Controlled Release of Simvastatin from In situ Forming Hydrogel Triggers Bone Formation in MC3T3-E1 Cells
|
Park, Yoon Shin
|
|
2012
|
15 |
2 |
p. 367-376
|
artikel
|
| 7 |
Direct and Rapid Genotyping of SLCO1B1 388A>G and 521T>C in Human Blood Specimens Using the SmartAmp-2 Method
|
Yoshida, Kenta
|
|
2013
|
15 |
2 |
p. 618-622
|
artikel
|
| 8 |
Dose Selection Based on Physiologically Based Pharmacokinetic (PBPK) Approaches
|
Jones, Hannah M.
|
|
2012
|
15 |
2 |
p. 377-387
|
artikel
|
| 9 |
Drug Discovery and Regulatory Considerations for Improving In Silico and In Vitro Predictions that Use Caco-2 as a Surrogate for Human Intestinal Permeability Measurements
|
Larregieu, Caroline A.
|
|
2013
|
15 |
2 |
p. 483-497
|
artikel
|
| 10 |
Effect of Device Design on the Aerosolization of a Carrier-Based Dry Powder Inhaler—a Case Study on Aerolizer® Foradile®
|
Zhou, Qi Tony
|
|
2013
|
15 |
2 |
p. 511-522
|
artikel
|
| 11 |
External Validation of the Bilirubin–Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients
|
Rekić, Dinko
|
|
2012
|
15 |
2 |
p. 308-315
|
artikel
|
| 12 |
Highly Stabilized Curcumin Nanoparticles Tested in an In Vitro Blood–Brain Barrier Model and in Alzheimer’s Disease Tg2576 Mice
|
Cheng, Kwok Kin
|
|
2012
|
15 |
2 |
p. 324-336
|
artikel
|
| 13 |
Improper Selection of a Pre-specified Primary Dose–Response Analysis Delays Regulatory Drug Approval
|
Liu, Jiang
|
|
2013
|
15 |
2 |
p. 407-414
|
artikel
|
| 14 |
Influences of Organic Cation Transporter Polymorphisms on the Population Pharmacokinetics of Metformin in Healthy Subjects
|
Yoon, Hwa
|
|
2013
|
15 |
2 |
p. 571-580
|
artikel
|
| 15 |
In Vitro and In Vivo Evaluation of Amorphous Solid Dispersions Generated by Different Bench-Scale Processes, Using Griseofulvin as a Model Compound
|
Chiang, Po-Chang
|
|
2013
|
15 |
2 |
p. 608-617
|
artikel
|
| 16 |
In Vivo Quantitative Prediction of the Effect of Gene Polymorphisms and Drug Interactions on Drug Exposure for CYP2C19 Substrates
|
Goutelle, Sylvain
|
|
2013
|
15 |
2 |
p. 415-426
|
artikel
|
| 17 |
Modeling NSCLC Progression: Recent Advances and Opportunities Available
|
Suleiman, Ahmed Abbas
|
|
2013
|
15 |
2 |
p. 542-550
|
artikel
|
| 18 |
Modeling, Simulation, and Translation Framework for the Preclinical Development of Monoclonal Antibodies
|
Luu, Kenneth T.
|
|
2013
|
15 |
2 |
p. 551-558
|
artikel
|
| 19 |
Nonaqueous Gel for the Transdermal Delivery of a DTPA Penta-ethyl Ester Prodrug
|
Zhang, Yong
|
|
2013
|
15 |
2 |
p. 523-532
|
artikel
|
| 20 |
Organic Cation Transporter OCTs (SLC22) and MATEs (SLC47) in the Human Kidney
|
Motohashi, Hideyuki
|
|
2013
|
15 |
2 |
p. 581-588
|
artikel
|
| 21 |
Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients
|
Nyholm, Dag
|
|
2012
|
15 |
2 |
p. 316-323
|
artikel
|
| 22 |
Population-Based Efficacy Modeling of Omalizumab in Patients with Severe Allergic Asthma Inadequately Controlled with Standard Therapy
|
Zhu, Rui
|
|
2013
|
15 |
2 |
p. 559-570
|
artikel
|
| 23 |
Predictions of In Vivo Prolactin Levels from In Vitro Ki Values of D2 Receptor Antagonists Using an Agonist–Antagonist Interaction Model
|
Petersson, Klas J.
|
|
2013
|
15 |
2 |
p. 533-541
|
artikel
|
| 24 |
Regional-Dependent Intestinal Permeability and BCS Classification: Elucidation of pH-Related Complexity in Rats Using Pseudoephedrine
|
Fairstein, Moran
|
|
2013
|
15 |
2 |
p. 589-597
|
artikel
|
| 25 |
Regulatory Administrative Databases in FDA's Center for Biologics Evaluation and Research: Convergence Toward a Unified Database
|
Smith, Jeffrey K.
|
|
2012
|
15 |
2 |
p. 388-394
|
artikel
|
| 26 |
Simultaneous Analysis of Multiple Monoclonal Antibody Biotherapeutics by LC-MS/MS Method in Rat Plasma Following Cassette-Dosing
|
Li, Hongyan
|
|
2012
|
15 |
2 |
p. 337-346
|
artikel
|
| 27 |
Simultaneous Pharmacokinetic Model for Rolofylline and both M1-trans and M1-cis Metabolites
|
Stroh, Mark
|
|
2012
|
15 |
2 |
p. 498-504
|
artikel
|
| 28 |
Strategic Applications of Gene Expression: From Drug Discovery/Development to Bedside
|
Bai, Jane P. F.
|
|
2013
|
15 |
2 |
p. 427-437
|
artikel
|
| 29 |
Strategic Applications of Gene Expression: From Drug Discovery/Development to Bedside
|
Bai, Jane P. F.
|
|
|
15 |
2 |
p. 427-437
|
artikel
|
| 30 |
Strategic Biomarkers for Drug Development in Treating Rare Diseases and Diseases in Neonates and Infants
|
Bai, Jane P. F.
|
|
2013
|
15 |
2 |
p. 447-454
|
artikel
|
| 31 |
TargetHunter: An In Silico Target Identification Tool for Predicting Therapeutic Potential of Small Organic Molecules Based on Chemogenomic Database
|
Wang, Lirong
|
|
2013
|
15 |
2 |
p. 395-406
|
artikel
|
| 32 |
The Challenges of Assessing Osteoarthritis and Postoperative Pain in Dogs
|
Sharkey, Michele
|
|
2013
|
15 |
2 |
p. 598-607
|
artikel
|
| 33 |
The Interaction of Fatty Acid Amide Hydrolase (FAAH) Inhibitors with an Anandamide Carrier Protein Using 19F-NMR
|
Zhuang, Jianqin
|
|
2013
|
15 |
2 |
p. 477-482
|
artikel
|
| 34 |
The Twofold Advantage of the Amorphous Form as an Oral Drug Delivery Practice for Lipophilic Compounds: Increased Apparent Solubility and Drug Flux Through the Intestinal Membrane
|
Dahan, Arik
|
|
2012
|
15 |
2 |
p. 347-353
|
artikel
|
| 35 |
Translational Pharmacokinetic-Pharmacodynamic Modeling from Nonclinical to Clinical Development: A Case Study of Anticancer Drug, Crizotinib
|
Yamazaki, Shinji
|
|
2012
|
15 |
2 |
p. 354-366
|
artikel
|
Tijdschrift beschrijving